Pharmaceuticals, Biotechnology and Life Sciences
Patients who received Opdivo after surgery lived nearly twice as long without disease recurrence compared to those who received placebo…
New data presented from NUBEQA® (darolutamide) and Xofigo® (radium Ra 223 dichloride) studies demonstrate Bayer’s continued commitment to ongoing prostate…
With a median follow-up of two years, OPDIVO in combination with CABOMETYX continues to demonstrate superior progression-free survival, overall survival…
– Results of retrospective analysis demonstrate a 61% intracranial response rate in patients with progressing brain metastases – – Data…
With a median follow-up of two years, Cabometyx® in combination with Opdivo® continues to demonstrate superior progression-free survival, overall survival…
Broadened Hepatitis B Virus (HBV) Program with EDP-721, a New Oral HBV RNA Destabilizer, as a Potential Component of a…
– Mark Mallon to step down as CEO; Board appoints Thomas McCourt as interim CEO – – Julie McHugh to…
Timothy J. Scannell, President and Chief Operating Officer of Stryker Corporation, elected to board of directors ST. HELIER, Jersey–(BUSINESS WIRE)–$NVCR–Novocure…
World reknowned medical and clinical experts to guide Genprex’ novel gene therapy clinical development programs in cancer and diabetes, including…
Founding CEO Dr C. Glenn Begley transitions to advisory role MELBOURNE, Australia–(BUSINESS WIRE)–BioCurate, an independently operated joint venture between the…